.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Farmers Insurance
Accenture
Deloitte
US Department of Justice
Queensland Health
Chinese Patent Office
Teva
Federal Trade Commission
Colorcon

Generated: June 27, 2017

DrugPatentWatch Database Preview

Clonidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for clonidine hydrochloride and what is the scope of clonidine hydrochloride freedom to operate?

Clonidine hydrochloride
is the generic ingredient in five branded drugs marketed by Hikma Farmaceutica, Zydus Pharms Usa Inc, Duramed Pharms Barr, Prinston Inc, Teva, Luitpold, Boehringer Ingelheim, Mylan Institutional, Mylan, Actavis Elizabeth, Frontida Biopharm, Sun Pharm Inds Inc, Concordia Pharms Inc, Warner Chilcott, Interpharm, Par Pharm, Watson Labs, Exela Pharma Scs Llc, Alembic Pharms Ltd, Fresenius Kabi Usa, Am Therap, Anchen Pharms, Chartwell Molecules, Aurolife Pharma Llc, Unichem, Yung Shin Pharm, and Impax Labs, and is included in fifty-five NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for clonidine hydrochloride. Fifty-nine suppliers are listed for this compound.

Summary for Generic Name: clonidine hydrochloride

Tradenames:5
Patents:1
Applicants:27
NDAs:55
Drug Master File Entries: see list21
Suppliers / Packagers: see list59
Bulk Api Vendors: see list78
Clinical Trials: see list2,449
Patent Applications: see list1,983
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clonidine hydrochloride at DailyMed

Pharmacology for Ingredient: clonidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
INJECTABLE;INJECTION200300-002Jan 26, 2011APRXNoNo► Subscribe► Subscribe
Impax Labs
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL078099-002Aug 27, 2009ABRXNoNo► Subscribe► Subscribe
Warner Chilcott
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL072138-001Jun 13, 1988DISCNNoNo► Subscribe► Subscribe
Watson Labs
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL070395-001Mar 23, 1987DISCNNoNo► Subscribe► Subscribe
Interpharm
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL071254-001Oct 1, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clonidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-001Sep 30, 20095,869,100► Subscribe
Concordia Pharms Inc
KAPVAY
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-003Sep 28, 20105,869,100► Subscribe
Boehringer Ingelheim
CATAPRES
clonidine hydrochloride
TABLET;ORAL017407-001Approved Prior to Jan 1, 19823,454,701► Subscribe
Boehringer Ingelheim
CATAPRES
clonidine hydrochloride
TABLET;ORAL017407-003Approved Prior to Jan 1, 19823,454,701► Subscribe
Concordia Pharms Inc
KAPVAY
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-004Sep 28, 20105,869,100► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
McKinsey
Boehringer Ingelheim
US Department of Justice
Farmers Insurance
Mallinckrodt
Teva
Citi
Cerilliant
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot